therapy for acute myelogenous leukemia (AML) has remained essentially unchanged for 40 years and is, too often, debilitating and ineffective—especially in older patients. Development of new ...

Acute myelogenous leukemia (AML) is seen in this stock image. Duke researchers have discovered a new combination of drugs that is more effective than chemotherapy at killing acute myeloid leukemia ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

This milestone ensures expanded accessibility of critical treatments to patients diagnosed with acute myeloid leukemia (AML). Regulatory compliance in the UK and Switzerland has been achieved ...